PPARγ downregulation in colonic CD8+ T cells results in epithelial barrier disruption in people with HIV on antiretroviral therapy
Upasana Das AdhikariiD, Leah M. FroehleiD, Alexandra N. Pipkin, Heeva BaharlouiD, Alice H. LinderiD, Palak Shah, Amanda M. Hussey, Qiming ZhangiD, Sarah K. NyquistiD, Saleh KhawalediD, Fangtao ChiiD, Swagata GoswamiiD, Sabhyata Sedhain, Salina HussainiD, Thomas J. Diefenbach, Benjamin J. ReadiD, Byungji KimiD, Darrell J. IrvineiD, Osaretin E. AsowataiD, Mark S. LadinskyiD, Pamela J. BjörkmaniD, Fusi MadelaiD, Shakeel KaderiD, Alex K. ShalekiD, Musie S GhebremichaeliD, , Douglas S. KwoniD
Abstract
A hallmark of HIV infection is disruption of intestinal barrier integrity that persists in people with HIV (PWH) despite treatment with antiretroviral therapy (ART). This disruption is central to HIV disease progression, yet the causes remain incompletely understood. We report a novel mechanism by which immunometabolic defects in colon resident CD8+ T cells in PWH lead to intestinal epithelial apoptosis and disruption of intestinal barrier integrity. We show that in PWH, these cells downregulate the lipid sensor peroxisome proliferator-activated receptor-{gamma} (PPAR{gamma}), which results in reduced intracellular lipid droplets, impaired fatty acid oxidation, and acquisition of lipids by CD8+ T cells from intestinal epithelial cells, which then contributes to epithelial cell death. Our findings indicate that HIV-associated immunometabolic dysregulation of colon CD8+ T cell leads to loss of intestinal epithelial homeostasis. These results identify potential new strategies to reduce comorbidities in PWH and other disorders with disrupted intestinal barrier integrity.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 20
- FWCI
- 6.79
- Field percentile
- top 2%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Colon resident CD8+ T cells from people with HIV on antiretroviral therapy exhibit mitochondrial dysfunction and impaired responses
U. Das Adhikari, P. V. Shah, … D. S. Kwon·bioRxiv·May 2, 2023
- Dietary Indoles Modulate Gut Barrier Integrity via the AhR-IL-22 Axis in ART-Treated SIV Infection
Siva Thirugnanam, Alison R. Van Zandt, … Namita Rout·bioRxiv·Dec 8, 2025
- Ongoing lymphoid HIV production drives pyroptosis and GLP-1 counter-regulation in ART-suppressed infection
Peter A Crawford, Joshua Rhein, … Timothy W. Schacker·bioRxiv·Jan 10, 2026
- ART duration and immunometabolic state determine efficacy of DC-based treatment restoring functional HIV- specific CD8+ T cells in PLWH.
M. Calvet-Mirabent, I. Sanchez-Cerrillo, … E. M.-G. Martin-Gayo·bioRxiv·Jan 14, 2022
- HIV-1 infection is associated with depletion of germinal center B cells and a decrease in IgA+ plasma cells in the GI tract
Francesca Cossarini, Joan Shang, … Saurabh Mehandru·Science ImmunologyPeer-reviewed·Oct 25, 2024
- NLRP3 and NLRP1/CARD8 pathways differently contribute to pyroptosis of CD8+ T cells of ART-treated HIV patients
M. E. G. V. Roa, R. A. G. Cambu, … A. Pontillo·bioRxiv·May 15, 2023